Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CCNO, which has a previous symbol of UNG2, was erroneously identified as a uracil DNA glycosylase in PubMed ID: 2001396. Additionally we are shipping Cyclin O Kits (12) and Cyclin O Proteins (5) and many more products for this protein.
Showing 10 out of 57 products:
Human Polyclonal CCNO Primary Antibody for WB - ABIN2473144
Martin, Holcomb, Foster: Major hepatic resections in children. in Journal of pediatric surgery 1975
Show all 3 Pubmed References
Human Polyclonal CCNO Primary Antibody for WB - ABIN2473146
Kalis, Quie, Balfour: Measles (rubeola) susceptibility among elementary schoolchildren. in American journal of epidemiology 1975
Show all 2 Pubmed References
Human Polyclonal CCNO Primary Antibody for IHC, IHC (p) - ABIN4301641
Wallmeier, Al-Mutairi, Chen, Loges, Pennekamp, Menchen, Ma, Shamseldin, Olbrich, Dougherty, Werner, Alsabah, Köhler, Jaspers, Boon, Griese, Schmitt-Grohé, Zimmermann, Koerner-Rettberg, Horak, Kintner et al.: Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile cilia. ... in Nature genetics 2014
Ccno-deficient multiciliated cells fail to sufficiently generate deuterosomes, and only reduced numbers of fully functional centrioles that undergo maturation to ciliary basal bodies are formed.
We thus conclude that cyclin O, as an upstream regulator of MPF (show MSLN Antibodies), plays an important role in oocyte meiotic resumption in mouse oocytes.
Results show uracil-N-glycosylase (UNG (show UNG Antibodies)) as a new molecular layer that shapes the specificity of activation-induced deaminase (show AICDA Antibodies) (AID)-induced mutations and may provide new insights into the role of AID in cancer development.
Cyclin O activation correlates with apoptosis induction in vivo.
This study presents the crystal structure of the DDB1-DCAF1 (show VPRBP Antibodies)-HIV-1-Vpr-uracil-DNA glycosylase (show UNG Antibodies) (cyclin U) complex.
CCNO is mutated more frequently than expected from the rare previous clinical case reports, leads to severe clinical manifestations, and should therefore be considered an important differential diagnosis of mucociliary clearance disorders.
CCNO mutations have a role in congenital mucociliary clearance disorder with reduced generation of multiple motile cilia
This publication corrected the mistaken attribution of uracil DNA glycosylase (show UNG Antibodies) activity to this gene.
This publication initially attributed 'uracil-DNA glycosylase (show UNG Antibodies)' activity to this gene and named it UNG2, but a later publication (PubMed ID: 8419333) more correctly identified UNG2/CCNO as a member of the cyclin (show PCNA Antibodies) protein family.
This gene, which has a previous symbol of UNG2, was erroneously identified as a uracil DNA glycosylase in PubMed ID: 2001396. A later publication, PubMed ID: 8419333, identified this gene's product as a cyclin protein family member. The UNG2 term is also used as a specific protein isoform name for the UNG gene (GeneID 7374), so confusion exists in the scientific literature and in some databases for these two genes.
, cyclin O
, cyclin U
, cyclin-like uracil-DNA glycosylase
, uracil DNA glycosylase 2
, uracil-DNA glycosylase 2
, cyclin domain containing